Form 4 for APYX Apyx Medical Corp
Accepted 2022-08-31 00:00:00 ET · period of report 2022-08-29 · accession 0000719135-22-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-31 | 2022-08-29 | APYX | Goodwin Charles D. II | CEO, Dir | P - Purchase | $5.96 | +11.8K | 30.2K | +64% | +$70.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-29 | P | A | 9,750 | $5.97 | 40,000 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $5.90 to $5.99. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2022-08-29 | P | A | 2,000 | $5.93 | 30,250 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $5.92 to $5.93. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. |